The FDA approved Servier Pharmaceuticals’ Voranigo as a treatment for two types of low-grade gliomas. The drug, which is projected to become a blockbuster product, comes from Servier’s $1.8 ...
HLTH 2024, scheduled for October 20-23 at the Venetian Expo Center in Las Vegas, will highlight new programming, a physicians roundtable, generative AI, the shifting landscapes of telemedicine ...
Recent estimates reveal that more than 1 billion people worldwide, including nearly 880 million adults and 159 million children, are living with obesity. It is a global health crisis that affects ...